Results 211 to 220 of about 839,337 (241)

COVID-19 mRNA-1273 vaccination induced mast cell activation with strongly elevated Th₂ cytokines in a systemic mastocytosis patient. [PDF]

Inflamm Res
Weiss-Tessbach M, Haider T, Gowran A, Schubert L, Mühlbacher J, Brankovic J, Wahrmann M, Jilma B, Boehm T.   +8 more
europepmc   +1 more source

Medium-vessel vasculitis following COVID-19 moderna (mRNA-1273) vaccination and the utility of PET-CT as a diagnostic tool: a case report. [PDF]

EJNMMI Rep
Cherk MH, Zolio L, Khan S, Brady S.
europepmc   +1 more source

Immunogenicity of Monovalent mRNA-1273 and BNT162b2 Vaccines in Children <5 Years of Age. [PDF]

Pediatrics
Dalapati T, Williams CA, Giorgi EE, Hurst JH, Herbek S, Chen JL, Kosman C, Rotta AT, Turner NA, Pulido N, Aquino JN, Pfeiffer TS, Rodriguez J, Fouda GG, Permar SR, Kelly MS.   +15 more
europepmc   +1 more source

Immune Imprinting, Non-Durable Hybrid Immunity, and Hybrid Immune Damping Following SARS-CoV-2 Primary Vaccination with BNT162b2 and Boosting with mRNA-1273. [PDF]

Vaccines (Basel)
Erice A, Nuño N, Prieto L, Caballero C.
europepmc   +1 more source

Omicron COVID-19 immune correlates analysis of a third dose of mRNA-1273 in the COVE trial. [PDF]

Nat Commun
Zhang B, Fong Y, Fintzi J, Chu E, Janes HE, Kenny A, Carone M, Benkeser D, van der Laan LWP, Deng W, Zhou H, Wang X, Lu Y, Yu C, Borate B, Chen H, Reeder I, Carpp LN, Houchens CR, Martins K, Jayashankar L, Huynh C, Fichtenbaum CJ, Kalams S, Gay CL, Andrasik MP, Kublin JG, Corey L, Neuzil KM, Priddy F, Das R, Girard B, El Sahly HM, Baden LR, Jones T, Donis RO, Koup RA, Gilbert PB, Follmann D, United States Government (USG) COVID-19 Immune Assays Team, Moderna, Inc. Team, Coronavirus Vaccine Prevention Network (CoVPN)/Coronavirus Efficacy (COVE) Team, USG/CoVPN Biostatistics Team.   +43 more
europepmc   +1 more source

Real-World Effectiveness of a Third Dose of mRNA-1273 versus BNT162b2 on Inpatient and Medically Attended COVID-19 among Immunocompromised Adults in the United States [PDF]

Tianyu Sun, Linwei Li, Katherine E. Mues, Mihaela Georgieva, Brenna Kirk, James A. Mansi, Nicolas Van de Velde, Ekkehard Beck   +7 more
openalex   +1 more source

A case of biopsy-proven inflammatory dilated cardiomyopathy following heterologous mRNA-1273 third-dose immunization. [PDF]

ESC Heart Fail
Hashimoto K, Yamamoto H, Ikeda Y, Isogai J, Hashimoto T.   +4 more
europepmc   +1 more source

Profiling antibody epitopes induced by mRNA-1273 vaccination and boosters

, 2023
Girard B, Baum-Jones E, Best R, Campbell T, Coupart J, Dangerfield K, Dhal A, Jhatro M, Martinez B, Reifert J, Shon J, Zhang M, Waitz R, Chalkias S, Edwards D, Maglinao M, Paris R, Pajon R.   +17 more
europepmc   +1 more source

Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Adults with Underlying Medical Conditions: Systematic Literature Review and Pairwise Meta-Analysis Using GRADE. [PDF]

Adv Ther
Wang X, Pahwa A, Bausch-Jurken MT, Chitkara A, Sharma P, Malmenäs M, Vats S, Whitfield MG, Lai KZH, Dasari P, Gupta R, Nassim M, Van de Velde N, Green N, Beck E.   +14 more
europepmc   +1 more source

Immunostimulatory/immunodynamic model of mRNA-1273 to guide pediatric vaccine dose selection

, 2023
Attarwala H, Deng W, Ding B, Schnyder Ghamloush S, Girard B, Iqbal J, Ivaturi V, Minnikanti S, Zhou H, Miller J, Das R.   +10 more
europepmc   +1 more source